Phase 3 Ketamine Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Nebulized Ketamine for the Treatment of Major Depressive Disorder
MidazolamDepressive SymptomSevere Depression+14 more
Theresa Jacob, PhD, MPH40 enrolled1 locationNCT06752759
Recruiting
Phase 3
Fentanyl or Esketamine for Traumatic PAIN (FORE-PAIN) Trial
AnalgesiaEsketamineFentanyl+2 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)608 enrolled1 locationNCT06051227
Active
Phase 3
A study to evaluate whether increased codeine levels are seen when both codeine and ketamine are given in small doses to well volunteers.
The possibility that ketamine,an anaesthetic medication but which is also used at much lower doses, to help try and control severe chronic nerve pain, may increase the effective blood levels of opioids such as codeine or morphine that are often given in conjunction with ketamine.This study is looking at drug metabolism not pain management or anaesthesiology
Flinders University- Department of Clinical Pharmacology10 enrolled1 locationACTRN12610000283077